细胞生物学
糖基化
肿瘤坏死因子α
下调和上调
巨噬细胞
转录组
N-连接糖基化
基因剔除小鼠
生物
基诺美
磷酸化
化学
激酶
炎症
天冬酰胺
旁分泌信号
串扰
巨噬细胞极化
异质核核糖核蛋白
细胞信号
信号转导
补体系统
蛋白激酶A
NFKB1型
免疫学
细胞适应
作者
Yiming Dong,Handong Wang,王一丹,Simeng Lv,Jianhong Shi,Yawei Liu,Yingke Yan,Yongfang Zhang,Hongkun Xue,Hongkun Xue,Kun Liu,Zhiming Zhao,Wenhui Yang,Yiyi Zhang,Yibo Liu,Bingyan Guo,Longfei Li,Hongshan Yin,Xiang Gao,Chuan Wang
标识
DOI:10.1161/circresaha.126.329008
摘要
BACKGROUND: Macrophage polarization and complement activation play a pivotal role in the pathogenesis of myocardial ischemia-reperfusion (I/R) injury. FGF13 (fibroblast growth factor 13) is a critical regulator of cardiac homeostasis. However, the role and mechanism of FGF13 in myocardial I/R injury remain unclear. METHODS: FGF13 expression was detected in cardiomyocytes after hypoxia/reoxygenation and in hearts subjected to myocardial I/R. Cardiomyocyte-specific FGF13 knockout and adeno-associated virus serotype 9-mediated overexpression mice were generated. Transcriptomic and proteomic analyses identified key downstream mechanisms. Immunoprecipitation-mass spectrometry, co-immunoprecipitation, and glycoproteomics identified PGRN (progranulin) as an FGF13-interacting protein and mapped its glycosylation site. Mechanistic studies were performed using Transwell cocultures of neonatal mouse cardiomyocytes and bone marrow-derived macrophages, together with molecular and biochemical approaches. Virtual screening and molecular dynamics simulations identified a small-molecule FGF13 inhibitor. RESULTS: FGF13 was upregulated in cardiomyocytes after myocardial I/R. Cardiomyocyte-specific FGF13 knockout alleviated, whereas overexpression exacerbated, cardiac dysfunction and myocardial injury after I/R. Mechanistically, FGF13, through its asparagine 121 residue, competitively occupied the asparagine 263 glycosylation site of PGRN, sterically preventing STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A)-mediated glycosylation of asparagine 263 and suppressing PGRN secretion. FGF13 depletion restored PGRN glycosylation and secretion, which activated macrophage TNFR2/PI3K/AKT (tumor necrosis factor receptor 2/phosphoinositide 3-kinase/protein kinase B) signaling in a paracrine manner, promoted M2 polarization while suppressing M1 polarization, and inhibited complement activation and inflammation. The small-molecule FGF13 inhibitor CWD8 (1-[2-amino-2-methylpropyl]-5,5-dimethylpiperidin-3-ol) also attenuated myocardial I/R injury. CONCLUSIONS: Our findings highlight the critical role of FGF13 in myocardial I/R injury and reveal a competitive mechanism by which FGF13 hinders STT3A-mediated PGRN glycosylation. We identify the PGRN glycosylation-PI3K/AKT axis as the key downstream pathway mediating FGF13-regulated macrophage polarization and complement activation, suggesting that small-molecule FGF13 inhibitors may represent a promising therapeutic strategy for myocardial I/R injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI